Physician profile
Lillian Man
NPI 1780028985
$898.00
in general payments reported to CMS, 2019-2025
18 companies · $136 in 2025
The $136 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $182 · 2021: $27.84 · 2022: $316 · 2023: $22.20 · 2024: $81.72 · 2025: $136.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $240.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $250.67 | 2019-2025 | Opdualag, Opdivo |
| Genentech USA, INC. | $125.41 | 2022 | |
| Pfizer INC. | $91.84 | 2020 | |
| Eisai INC. | $90.36 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $56.97 | 2024-2025 | Calquence, Lynparza |
| Daiichi Sankyo INC. | $44.33 | 2025 | Datroway, Enhertu |
| Novartis Pharmaceuticals Corporation | $40.62 | 2019 | |
| Recordati_rare_diseases_inc. | $23.44 | 2025 | Panhematin |
| Seagen INC. | $20.40 | 2019 | |
| Pharmacyclics LLC, An Abbvie Company | $20.28 | 2020 | |
| Novocure INC. | $20.24 | 2020 | |
| Clovis Oncology, INC. | $19.21 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.66 | 2020 | |
| Foundation Medicine, INC. | $17.54 | 2020 | |
| Amgen INC. | $16.53 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $15.99 | 2019 | |
| Lilly USA, LLC | $13.59 | 2020 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Man listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.